Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
bid, biomarker, BNP, candidate, CellProthera, CIRM, confidence, contingent, criterion, dataset, delisted, delisting, diastolic, equivalent, fail, forward, gaining, greater, harder, higher, imminently, implantation, impossible, INDEX, LVAD, MINE, minute, mortality, Nasdaq, newly, nondilutive, outpatient, protocol, QUALITATIVE, QUANTITATIVE, ranging, rationale, reduction, regain, Regenerative, replacement, representative, runway, satisfy, SENIOR, simplify, sized, small, subset, threshold, understand, UNREGISTERED, unrelated, volume, worsening
Removed:
Breakthrough, Canada, CBER, designation, February, Food, guidance, prespecified, survival, treat
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view